Aggregate Spend

AGGREGATE SPEND SOFTWARE WHITE PAPERS AND CASE STUDIES

AGGREGATE SPEND PRODUCTS

Ensuring Safe Handling of High-Risk Biological Agents

Gloveboxes serve the needs of a diverse range of industries including biotechnology, biomedical, nuclear, defense, pharmaceutical, semiconductor and chemical applications. When these enclosures are used for microbiological research or to handle pathogens, they are referred to as Class III Biosafety Cabinets.

Unlock unmatched performance with the Empower RF Model 2217, a robust high-power RF amplifier designed to deliver a minimum of 8kW peak pulsed power for demanding applications.

The HLM-70ACH is a high-power GaAs Schottky diode signal limiter. It offers low insertion loss and low return loss from DC through V band.

The ADM-9027PSM is a wideband distributed low noise amplifier capable of providing 16 dB gain and +25 dBm OIP3 from 2 to 20 GHz and a low 1.8 dB typical noise figure from 8 to 16 GHz.

The MAAP-011379 is a 1W distributed power amplifier offered in die form. The power amplifier operates from 20 to 55 GHz and provides 22 dB of linear gain and 30 dBm saturated output power. 

The MFLP-00007CH is a passive MMIC surface mount 2 GHz lowpass filter that is an ideal solution for small form factor, high rejection filtering.

We help clients optimize manufacturing and packaging operations by implementing engineering and automation solutions that improve quality and reduce operating costs.

DSI’s photolithography capability produces patterned thin film coatings (including bandpass filters, absorption coatings, and metals) on substrates up to 6 inches.

AGGREGATE SPEND SOFTWARE NEWS

ABOUT

Aggregate Spend

Aggregate Spend refers to the process used to aggregate and monitor the total amount spent on organizations and individual healthcare professionals by healthcare manufacturers. The amount spent is aggregated in terms of payments made, honoraria, gifts, travel and other means. Aggregate spend is also known as the Physician Spend Sunshine Law which is an initiative that is aimed to achieve transparency in life sciences industry, the benefits of each physician as well as to limit spend per physician. The law is a body of state and federal legislations. Passing of this law was also in effort to alleviate the conflicts of interest between pharmaceutical and medical device companies and healthcare professionals.

The process requires that manufactures of various medical devices, drugs, biological and other supplies recorded all payments made to physicians including any other transfers of value to teaching hospitals and physicians. Report regarding all this information is required to be produced annually by all the applicable manufacturers and suppliers. The manufacturers are required to include details such as date, nature of payment and the value. Penalties are charged in case of breaching this law by the target parties.

By doing this, accountability of individual physicians and medical device, pharmaceutical and life sciences companies can be achieved. The challenge now is to the life science companies to address the reporting requirements and more so now that state and federal regulatory agency continue to enact legislation that require more auditing of monetary transactions to physicians and organizations involved in healthcare management. As a result many companies are now working more diligently to address compliance and gain more competitive advantage through reputation management among other ways.